Bipolar
New Data, New Directions In Management Of Mood And Anxiety Disorders - 8th International Forum For Mood And Anxiety Disorders Congress
Schizophrenia And Bipolar Disorder - Clinical Feasibility Of Once-a-Day Ziprasidone
SEROQUEL XRâ„¢ And SEROQUEL(R) Approved In Europe For New Indications For The Treatment Of Bipolar Disorder
Repligen Initiates Phase 2b Clinical Trial Of RG2417 In Bipolar Disorder
One In Five Hospital Admissions Are For Patients With Mental Disorders, USA
Bipolar Disorder Involves A Lower Quality Of Both Mental And Physical Life, Even In Periods Of Normality
During A Response-Imaging Task, MRI Brain Activity In First-Episode Bipolar Mania
Both Mental And Physical Quality Of Life Affected By Bipolar Disorder
Two Per Cent Of People In England In Contact With NHS Specialist Mental Health Services, New Report Shows
Patient Groups Tackle Stigma Attached To Bipolar Disorder And Other Mental Illnesses With New Tools
Healthcare Commission Needs To Raise The Bar For Mental Health Service Users, UK
Manhattan Research Announces Top Condition Groups Shifting Their TV Viewing Online
Awareness Campaign - To Dispel Myths About Mood Disorders - Mood Disorders Association Of Ontario
Childhood Bipolar Disorder Could Extend Into Young Adulthood
Forest Laboratories, Inc. And Gedeon Richter Plc Announce Positive Phase II Results With The Investigational Antipsychotic Cariprazine
Global Psychiatrists Unite To Improve Services In Mental Health
AstraZeneca's Seroquel XL, Once Daily Formula, Now Available For UK Patients
52 Percent Of Newly Diagnosed Bipolar Disorder Patients Receive Antidepressant Drugs In First-Line Treatment
Clues To Rapid Cycling Bipolar Disease
Teva Announces Appellate Court Reverses Generic Risperdal(R) Exclusivity Decision
Seroquel XL (Quetiapine Prolonged Release): A Once Daily Formulation For Bipolar Mania And Schizophrenia Launches Today, UK
Family Therapy With Medication Improves Depression In Bipolar Teens
Healthy Minds Across America Features 48 Public Forums On Mental Health Research, Sept. 14
High Incidence Of Mental Disorders Revealed In Young Offender Institutions
New Data Highlight Benefit Of SEROQUEL Monotherapy For Long-Term Treatment Of Bipolar Disorder






Today's Total Visit  5911............